ArticleScientific reports2021

Low-dose aspirin confers a survival benefit in patients with pathological advanced-stage oral squamous cell carcinoma.

Sheng-Dean Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.